These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

409 related articles for article (PubMed ID: 24111828)

  • 1. Potentials of proniosomes for improving the oral bioavailability of poorly water-soluble drugs.
    Song S; Tian B; Chen F; Zhang W; Pan Y; Zhang Q; Yang X; Pan W
    Drug Dev Ind Pharm; 2015 Jan; 41(1):51-62. PubMed ID: 24111828
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enhanced oral bioavailability of isradipine via proniosomal systems.
    Veerareddy PR; Bobbala SK
    Drug Dev Ind Pharm; 2013 Jun; 39(6):909-17. PubMed ID: 22998221
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Optimized preparation of vinpocetine proliposomes by a novel method and in vivo evaluation of its pharmacokinetics in New Zealand rabbits.
    Xu H; He L; Nie S; Guan J; Zhang X; Yang X; Pan W
    J Control Release; 2009 Nov; 140(1):61-8. PubMed ID: 19651165
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Single Intravenous Dose of Novel Flurbiprofen-Loaded Proniosome Formulations Provides Prolonged Systemic Exposure and Anti-inflammatory Effect.
    Verma P; Prajapati SK; Yadav R; Senyschyn D; Shea PR; Trevaskis NL
    Mol Pharm; 2016 Nov; 13(11):3688-3699. PubMed ID: 27632682
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel oral delivery system consisting in "drug-in cyclodextrin-in nanostructured lipid carriers" for poorly water-soluble drug: vinpocetine.
    Lin C; Chen F; Ye T; Zhang L; Zhang W; Liu D; Xiong W; Yang X; Pan W
    Int J Pharm; 2014 Apr; 465(1-2):90-6. PubMed ID: 24530388
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A review on novel vesicular drug delivery: proniosomes.
    Yasam VR; Jakki SL; Natarajan J; Kuppusamy G
    Drug Deliv; 2014 Jun; 21(4):243-9. PubMed ID: 24128089
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Proniosome-derived niosomes for tacrolimus topical ocular delivery: in vitro cornea permeation, ocular irritation, and in vivo anti-allograft rejection.
    Li Q; Li Z; Zeng W; Ge S; Lu H; Wu C; Ge L; Liang D; Xu Y
    Eur J Pharm Sci; 2014 Oct; 62():115-23. PubMed ID: 24905830
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhancement of Dissolution and Skin Permeability of Pentazocine by Proniosomes and Niosomal Gel.
    Madni A; Rahim MA; Mahmood MA; Jabar A; Rehman M; Shah H; Khan A; Tahir N; Shah A
    AAPS PharmSciTech; 2018 May; 19(4):1544-1553. PubMed ID: 29470828
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel sugar esters proniosomes for transdermal delivery of vinpocetine: preclinical and clinical studies.
    El-Laithy HM; Shoukry O; Mahran LG
    Eur J Pharm Biopharm; 2011 Jan; 77(1):43-55. PubMed ID: 21056658
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Niosomes for oral delivery of nateglinide: in situ-in vivo correlation.
    Sultan AA; El-Gizawy SA; Osman MA; El Maghraby GM
    J Liposome Res; 2018 Sep; 28(3):209-217. PubMed ID: 28618876
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preparation and characterization of vinpocetine loaded nanostructured lipid carriers (NLC) for improved oral bioavailability.
    Zhuang CY; Li N; Wang M; Zhang XN; Pan WS; Peng JJ; Pan YS; Tang X
    Int J Pharm; 2010 Jul; 394(1-2):179-85. PubMed ID: 20471464
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In situ niosome forming maltodextrin proniosomes of candesartan cilexetil: In vitro and in vivo evaluations.
    Yuksel N; Bayindir ZS; Aksakal E; Ozcelikay AT
    Int J Biol Macromol; 2016 Jan; 82():453-63. PubMed ID: 26455402
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sucrose stearate-based proniosome-derived niosomes for the nebulisable delivery of cromolyn sodium.
    Abd-Elbary A; El-laithy HM; Tadros MI
    Int J Pharm; 2008 Jun; 357(1-2):189-98. PubMed ID: 18339494
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro and in vivo evaluation of proniosomes containing celecoxib for oral administration.
    Nasr M
    AAPS PharmSciTech; 2010 Mar; 11(1):85-9. PubMed ID: 20058106
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Improved Bioavailability and Antitumor Effect of Docetaxel by TPGS Modified Proniosomes: In Vitro and In Vivo Evaluations.
    Liu H; Tu L; Zhou Y; Dang Z; Wang L; Du J; Feng J; Hu K
    Sci Rep; 2017 Mar; 7():43372. PubMed ID: 28266539
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Technology overview and drug delivery application of proniosome.
    Ahmad MZ; Mohammed AA; Mokhtar Ibrahim M
    Pharm Dev Technol; 2017 May; 22(3):302-311. PubMed ID: 26794727
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel diphenyl dimethyl bicarboxylate provesicular powders with enhanced hepatocurative activity: preparation, optimization, in vitro/in vivo evaluation.
    Aburahma MH; Abdelbary GA
    Int J Pharm; 2012 Jan; 422(1-2):139-50. PubMed ID: 22079716
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Proniosomes as drug carriers.
    Sankar V; Ruckmani K; Durga S; Jailani S
    Pak J Pharm Sci; 2010 Jan; 23(1):103-7. PubMed ID: 20067875
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of proniosomes as an alternative strategy to optimize piroxicam transdermal delivery.
    Alsarra IA
    J Microencapsul; 2009 May; 26(3):272-8. PubMed ID: 18720197
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of some formulation parameters on flurbiprofen encapsulation and release rates of niosomes prepared from proniosomes.
    Mokhtar M; Sammour OA; Hammad MA; Megrab NA
    Int J Pharm; 2008 Sep; 361(1-2):104-11. PubMed ID: 18577437
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.